Bladder Neoplasm: Clinical Trials

1 trial for Bladder Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Bladder Neoplasm: new trials by email Literature Review of Bladder Neoplasm trials Research Report on Bladder Neoplasm

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
Pralatrexate Injection, Vitamin B12, Folic Acid - Carcinoma, Transitional Cell, Bladder Cancer
Phase 2CompletedAcrotech Biopharma Inc.302008-07-012019-12-17

Narrower conditions

Carcinoma (1)  ·  Carcinoma, Transitional Cell (1)  ·  Neoplasm Metastasis (1)  ·  Recurrence (1)  ·  Urinary Bladder Neoplasms (1)

Broader conditions

Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Urinary Bladder Diseases (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)  ·  Urologic Diseases (1)

Interventions

10-propargyl-10-deazaaminopterin (1)  ·  Folic Acid (1)  ·  Vitamin B 12 (1)

Sponsors

Acrotech Biopharma Inc. (1)

Countries

Argentina (1)  ·  Belgium (1)  ·  Croatia (1)  ·  France (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Garry Weems, Pharm.D. (1)